Price T Rowe Associates Inc Meridian Bioscience Inc Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$31.15 - $33.39 $24,920 - $26,712	-800 Reduced 2.86%	27,215 $904,000
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $41,282 - $44,822	1,336 Added 5.01%	28,015 $884,000
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $212,111 - $283,023	-8,931 Reduced 25.08%	26,679 $812,000
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $45,970 - $62,015	2,302 Added 6.91%	35,610 $924,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $45,396 - $56,186	-2,600 Reduced 7.24%	33,308 $679,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $14,281 - $22,457	793 Added 2.26%	35,908 $796,000
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $53,213 - $80,493	2,693 Added 8.31%	35,115 $922,000
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $509,998 - $702,260	32,422 New	32,422 $606,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.